RESUMEN

Membrane shape is a key feature of many cellular processes, including cell differentiation, division, migration, and trafficking. The development of nanostructured surfaces allowing for the in situ manipulation of membranes in living cells is crucial to understand these processes, but this requires complicated and limited-access technologies. Here, we investigate the self-organization of cellular membranes by using a customizable and benchtop method allowing one to engineer 1D SiO2 nanopillar arrays of defined sizes and shapes on high-performance glass compatible with advanced microscopies. As a result of this original combination, we provide a mapping of the morphology-induced modulation of the cell membrane mechanics, dynamics and steady-state organization of key protein complexes implicated in cellular trafficking and signal transduction.

Asunto(s)

RESUMEN

La realización de procedimientos invasivos en pacientes con anticoagulación oral es un riesgo. Sin unos datos concluyentes al respecto, las recomendaciones sobre el manejo, por lo general, son de escasa solidez, y su manejo es controvertido y heterogéneo. Se realiza una revisión de las evidencias sobre el manejo periprocedimiento electivo de la anticoagulación oral después de la publicación de la 9.ª edición de la guía del American College of Chest Physicians. Salvo en caso de procedimientos con riesgo hemorrágico mínimo, los anticoagulantes orales serán suspendidos justo con la antelación necesaria para que se realice sin efecto anticoagulante significativo, lo que dependerá de la vida media del fármaco, que en el caso de los anticoagulantes orales de acción directa está condicionada por la función renal. Estudios recientes muestran que la utilización de terapia puente con heparina en pacientes que interrumpen temporalmente la anticoagulación oral no aporta beneficios e incrementa los sangrados; sin embargo, no hay evidencia concluyente contra su uso en pacientes con alto riesgo tromboembólico (AU)

The performance of invasive procedures in patients undergoing oral anticoagulation represents a risk. Without conclusive data on this issue, the recommendations on managing oral anticoagulation are generally weak, and its management is controversial and heterogeneous. We conducted a review of the evidence on the elective periprocedural management of oral anticoagulation following the publication of the 9th edition of the guidelines of the American College of Chest Physicians. Except for cases of procedures with minimal haemorrhagic risk, the use of oral anticoagulants is suspended with sufficient time so that it can be performed without a significant anticoagulant effect, which will depend on the half-life of the drug. For direct oral anticoagulants, the half-life is determined by the renal function. Recent studies have shown that the use of bridge therapy with heparin in patients who temporarily suspended the use of oral anticoagulation provided no benefits and increased the bleeding. However, there is no conclusive evidence against its use in patients with a high thromboembolic risk (AU)

Asunto(s)

RESUMEN

The performance of invasive procedures in patients undergoing oral anticoagulation represents a risk. Without conclusive data on this issue, the recommendations on managing oral anticoagulation are generally weak, and its management is controversial and heterogeneous. We conducted a review of the evidence on the elective periprocedural management of oral anticoagulation following the publication of the 9th edition of the guidelines of the American College of Chest Physicians. Except for cases of procedures with minimal haemorrhagic risk, the use of oral anticoagulants is suspended with sufficient time so that it can be performed without a significant anticoagulant effect, which will depend on the half-life of the drug. For direct oral anticoagulants, the half-life is determined by the renal function. Recent studies have shown that the use of bridge therapy with heparin in patients who temporarily suspended the use of oral anticoagulation provided no benefits and increased the bleeding. However, there is no conclusive evidence against its use in patients with a high thromboembolic risk.

RESUMEN

No disponible

Asunto(s)

RESUMEN

No disponible

Asunto(s)

Asunto(s)

Asunto(s)

Asunto(s)

RESUMEN

No disponible

Asunto(s)

RESUMEN

A clinical and therapeutical study of 47 patients with the diagnosis of acute pancreatitis is reported. According to Ranson's criteria patients were initially classified as suffering from mild (28) and severe (18) acute pancreatitis. Twenty-eight, 11, 7 and 1 patients had biliary, alcoholic, idiopathic and neoplastic causes, respectively, of their conditions. The classification of episodes was made on the basis of clinical manifestations, biologic investigations, and imaging diagnosis, and is shown in the corresponding tables. The therapeutic profile was a randomized double-blind study: perfused somatostatin (SS) versus placebo (P) (physiologic saline 0.9%). The administration of somatostatin in perfusion (250 mcg/h/48 hours) did not improve significantly the parameters used to score the severity, although the mortality rate decreased significantly (p < 0.05) in the group of patients with the severe form of the disease.

Asunto(s)

Asunto(s)

Asunto(s)

RESUMEN

OBJECTIVES: Analyze the decision to enact or to refrain from chemoprophylaxis (CP) with isoniazide (INH) in patients who are intravenous drug users (IVDU) in Spain infected by the human immunodeficiency virus (HIV), either classified or not with hypersensitive skin tests. METHODS: With the bibliographic information available and the help of decision tree, an analysis of the effectiveness and of the consequences of drug costs of CP with INH in those patients is performed. RESULTS: Overall, the HIV+ IVDU benefit from CP is an increase in survival of 80 days, with a savings of 7,252 pesetas per patient. The intradermal reaction with PPD and the retarded hypersensitivity tests (HCR) allow us to classify them in three subgroups: a) PPD+ where CP is universally admitted and thus corroborates our study; b) PPD-/HCR- where CP increases survival 201 days and saves 20,616 pesetas per patient; and c) PPD-/HCR+ where survival is increased 33 days and the pharmacological costs increase 1,536 pesetas per patient under CP. CONCLUSIONS: For the present situation in Spain, CP with INH is effective in HIV+ IVDU patients, independent of the results of the intradermal reaction skin tests.

Asunto(s)

Asunto(s)

Asunto(s)

Asunto(s)

Asunto(s)

RESUMEN

The value of seric activity of adenosine deaminase has been detected in four group of patients with liver disease: acute viral hepatitis in 32 cases, liver cirrhosis in 30 cases, liver neoplasia in 12 cases, and cholelithiasis in 20 cases, against 30 patients as a control group. In addition, we studied 3 patients with alcoholic hepatitis and 1 with biliary cirrhosis. The highest level was found in hepatic cirrhosis and viral hepatitis the value being statistically significant and superior to the levels of the control group in 100% of the cases. This level was higher than normal in patients with liver tumor. The level was normal or mildly elevated in patients with cholelithiasis. The level was normal in patients with alcoholic hepatitis and high in biliary cirrhosis but lower than that observed in alcoholic cirrhosis.

Asunto(s)